Abstract
SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different viral antigens (spike protein and nucleoprotein) and among antibody classes (IgA, IgG, and IgM and neutralizing antibodies). The antibody peak is reached by 3 weeks from hospital admission followed by a sharp decrease. No difference was observed in any parameter of the antibody classes, including neutralizing antibodies, between subjects who recovered or with fatal outcome. Only few asymptomatic subjects developed antibodies at detectable levels.
Publisher
Public Library of Science (PLoS)
Reference47 articles.
1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020. 2020; Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.
2. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;R. Lu;Lancet,2020
3. The trinity of COVID-19: immunity, inflammation and intervention;M.Z. Tay;Nat Rev Immunol,2020
4. SARS-CoV-2 Vaccines: Status Report;F. Amanat;Immunity,2020
5. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;J.F. Chan;Lancet,2020
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献